Communications Biology vs Scientific Reports: Which Open-Access Journal?

• the paper advances biological understanding (not just reports correct data)
• you want a more selective Nature Portfolio venue than Scientific Reports
• the biology is strong and the significance is clear
• the higher selectivity (~35-40% vs 57%) adds perceived value

• the science is sound but novelty isn't the paper's strength
• you want the fastest path to a Nature Portfolio indexed publication
• negative results, replications, or descriptive work needs a home
• the broader scope (beyond just biology) matters

Use these questions before you pick:

• if the word "significance" disappeared, would the paper still obviously fit Communications Biology
• is the central claim interesting because it is biologically important, or because it is technically complete
• would a broader life-science editor see a real advance, or just a correct study
• is the audience mainly biology specialists, or simply anyone who needs the result to be published
• if Communications Biology says no, would Scientific Reports still feel like the same paper with only lighter framing changes

If the answer pattern points to technical soundness plus moderate novelty, Scientific Reports is usually the cleaner call. If the answer pattern points to clear biological insight and stronger selectivity, Communications Biology earns the risk.

If Communications Biology rejects the paper because the editors do not see a strong enough advance, Scientific Reports may still be a clean next step. That is especially true when the study is rigorous, the data package is complete, and the real weakness is significance rather than correctness. In that scenario, the science does not need to become a different study. It usually needs a more honest framing.

The more important distinction is why the first journal said no. If Communications Biology rejects because the biology story is underdeveloped, the mechanistic claim is thin, or the audience is too narrow, then Scientific Reports can still work because it is asking a different editorial question. But if the rejection is really about methods, reporting, controls, or unsupported interpretation, moving to Scientific Reports does not solve the underlying problem. A soundness journal still expects the paper to be genuinely sound.

The reverse signal matters too. If Scientific Reports feels too broad and impersonal for the paper, that does not automatically mean Communications Biology is right. Sometimes it means the better target is a specialty biology journal where the exact audience already exists and the paper does not need to stretch its significance language to compete.

These two journals are often compared because they sit in the same publisher portfolio, but that can hide the more strategic option. If the work is strongest for a specific community such as immunology, microbiology, plant biology, or developmental biology, a field journal can outperform both on readership quality. The paper may get less generic prestige signaling, but more of the right people will actually see it.

That tradeoff matters when the manuscript is solid and useful but not broad enough to win on portfolio-journal branding alone. In that case, the best submission is often the journal whose readers immediately care, not the one whose name looks safest on a ranking list.

The useful strategic move is to decide whether the paper fails upward or downward. Some manuscripts are close to Communications Biology because the biological insight is real but still under-argued. Those papers may deserve one serious revision before submission, not an immediate downgrade. Tightening the causal language, sharpening the mechanistic contribution, and cutting claims the data do not fully carry can change how the same dataset reads.

Other manuscripts are not close misses at all. They are rigorous, publishable studies whose value is mainly that the work is correct, complete, and available. Those papers are often damaged when authors keep trying to write them as significance-driven stories. Scientific Reports becomes stronger when the framing is honest about what the paper contributes and who needs it in the literature.

That distinction matters for ranking, credibility, and reader trust. The best version of this choice is not "Which Nature journal can I still get?" It is "Which editorial standard matches the strongest truthful version of this manuscript?" Authors who answer that directly usually submit faster, revise less, and land in a journal that fits the paper on its merits rather than on aspiration alone.

If you are genuinely torn between these two journals, the most useful exercise is to revise the abstract and discussion twice. In one version, write the paper as a significance-led biology story and ask whether the advance still feels sharp without inflated language. In the other, write it as a rigor-first contribution and ask whether the work still looks valuable without novelty-heavy framing.

That side-by-side exercise usually exposes the right destination. If the paper only works when the significance language is aggressive, Communications Biology is probably aspirational rather than realistic. If the paper still feels useful, coherent, and honest when it is framed as technically sound biology that belongs in the record, Scientific Reports becomes easier to justify. Good journal selection is often less about guessing editor psychology and more about seeing which truthful version of the manuscript is strongest.

Use this if you're stuck between the two and need a clear answer in under a minute.

Go with Communications Biology if all three are true:

1. The paper is biology or life sciences (not interdisciplinary physical science)
2. You can articulate why the finding advances biological understanding, not just that the data is correct
3. You're comfortable with a ~35-40% acceptance rate and the higher APC (~$3,090)

Go with Scientific Reports if any of these apply:

1. The paper's strength is rigor and completeness, not novelty
2. You need a faster, higher-probability path to a Nature Portfolio publication
3. The work is negative results, replication, or descriptive, all legitimate science that Comm Bio won't take

The volume tells its own story. Communications Biology publishes about 1,626 articles per year (JCR 2024). Scientific Reports publishes 25,000+. That 15:1 ratio means Sci Reports is functionally a different kind of journal, it's the Nature Portfolio's open archive for sound science, while Comm Bio is a curated selection. Neither is wrong; they're answering different questions about your manuscript.

Last verified: JCR 2024 release (June 2025), Communications Biology IF 5.1, JCI 1.52, Q1, rank 8/107 in Biology, 1,626 articles/year. Scientific Reports IF 3.9, JCI 1.07, Q1, rank 25/135 in Multidisciplinary Sciences.

In our pre-submission review work with manuscripts targeting both Communications Biology and Scientific Reports, three patterns generate the most consistent mismatch decisions among the papers we analyze.

Significance language that overstates the biological advance. Communications Biology's author guidelines require that papers represent "a significant advance in understanding" in biological research. We see manuscripts submitted to Communications Biology where the abstract and introduction use significance-heavy framing ("reveals a novel mechanism," "establishes a new paradigm") but where the data package supports a more modest conclusion. Editors and reviewers identify this gap between framing and evidence quickly. The paper that would be accepted with honest framing at Scientific Reports gets rejected at Communications Biology because the claimed significance does not hold up to scrutiny.

Scientific Reports submissions that still carry significance-framing from a previous rejection. When manuscripts move from Communications Biology to Scientific Reports, they sometimes retain significance-forward language from their previous submission without reframing for a soundness-based editorial standard. SciRev author reports on Scientific Reports rejections include feedback citing "overclaimed conclusions" and "unsupported mechanistic interpretations." We find that papers rejected from Communications Biology for thin functional evidence and then submitted to Scientific Reports without revising the interpretive framing face the same criticism from Scientific Reports reviewers: the paper claims more than the data show.

Misidentifying Scientific Reports as a fallback when a specialty journal is the correct target. Both journals publish broadly, and authors sometimes treat them as the only alternatives to high-selectivity journals. We observe manuscripts where the biology is sound and useful but deeply specialized (a specific microbial pathway, a niche metabolic mechanism, a narrow population genomics question) and would be better served by a field-specific journal whose readership immediately cares about the topic. Scientific Reports publishes the work, but citations and audience engagement reflect the mismatch. The right journal is often neither of these two.

SciRev author-reported data confirms Communications Biology's typical first-decision timeline of 2-4 weeks and Scientific Reports' approximately 21-day median to first decision. A Communications Biology vs. Scientific Reports editorial standard check can assess which editorial standard your biology manuscript actually meets before submission.